MedPath

Iron Absorption From GDS Capsules II

Not Applicable
Completed
Conditions
Iron Deficiency
Interventions
Dietary Supplement: GDS capsule with meal
Dietary Supplement: Ferrous sulfate with meal
Registration Number
NCT01985386
Lead Sponsor
Swiss Federal Institute of Technology
Brief Summary

Slow release iron capsules containing ferrous sulfate have been designed based on the gastric delivery system. Iron absorption from those capsules administered with and without meals will be measured using stable iron isotopes.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
8
Inclusion Criteria
  • female,
  • age 18-50 years,
  • max. body weight 65 kg,
  • serum ferritin < 30 µg/l
Exclusion Criteria
  • pregnancy,
  • lactation,
  • regular intake of medication,
  • blood donation or significant blood losses over the past 4 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
GDS (gastric delivery system), mealGDS capsule with mealGDS capsule with meal
Ferrous sulfate, mealFerrous sulfate with mealFerrous sulfate with meal
Primary Outcome Measures
NameTimeMethod
Fractional iron absorption2 weeks after test meal consumption
Secondary Outcome Measures
NameTimeMethod
Serum isotope appearance1, 2, 4 and 8 hours on days 1 and 8

Trial Locations

Locations (1)

Human Nutrition Laboratory, ETH Zurich

🇨🇭

Zurich, Switzerland

Human Nutrition Laboratory, ETH Zurich
🇨🇭Zurich, Switzerland
© Copyright 2025. All Rights Reserved by MedPath